Carmen Ricozzi
Overview
Explore the profile of Carmen Ricozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nevola R, Tortorella G, Rosato V, Rinaldi L, Imbriani S, Perillo P, et al.
Biology (Basel)
. 2023 Jul;
12(7).
PMID: 37508414
Several chronic liver diseases are characterized by a clear gender disparity. Among them, hepatocellular carcinoma (HCC) shows significantly higher incidence rates in men than in women. The different epidemiological distribution...
2.
Nevola R, Russo A, Scuotto S, Imbriani S, Aprea C, Abitabile M, et al.
Respir Res
. 2022 Dec;
23(1):327.
PMID: 36463178
Background: Acute respiratory distress syndrome (ARDS) is one of the most severe complications of SARS-CoV-2 infection. Non-Invasive Respiratory Support (NRS) as Continuous Positive Airway Pressure (CPAP) and/or Non-Invasive Ventilation (NIV)...
3.
Aprea C, Imbriani S, Cirigliano G, Gjeloshi K, Meo L, Padula A, et al.
Acta Biomed
. 2022 Jun;
93(S1):e2022102.
PMID: 35671104
Platypnea-Orthodeoxia Syndrome (POS) is an often misdiagnosed clinical condition characterized by dyspnea and hypoxia in sitting or semi-sitting position, reversible in supine position. Although POS is typically associated with intracardiac...
4.
Marrone A, Nevola R, Sellitto A, Cozzolino D, Romano C, Cuomo G, et al.
Clin Infect Dis
. 2022 Jan;
75(1):e403-e409.
PMID: 35084022
Background: Remdesivir is an antiviral used to treat coronavirus disease 2019 (COVID-19), which improves some clinical outcomes. Dexamethasone has been shown to be effective in reducing mortality. It has been...
5.
Garofalo C, De Stefano F, Gjeloshi K, De Gregorio I, Masini F, Ricozzi C, et al.
Nephrology (Carlton)
. 2021 Jun;
26(10):843-844.
PMID: 34060180
No abstract available.
6.
Monaco L, Sica A, Masini F, Pafundi P, Ricozzi C, Imbriani S, et al.
Minerva Surg
. 2021 Mar;
76(1):98-101.
PMID: 33754592
No abstract available.
7.
Salvatore T, Pafundi P, Galiero R, Rinaldi L, Caturano A, Vetrano E, et al.
Biomedicines
. 2020 Dec;
9(1).
PMID: 33375185
Cardiovascular mortality is a major cause of death among in type 2 diabetes (T2DM). Endothelial dysfunction (ED) is a well-known important risk factor for the development of diabetes cardiovascular complications....
8.
Salvatore T, Pafundi P, Marfella R, Sardu C, Rinaldi L, Monaco L, et al.
Diabetes Res Clin Pract
. 2019 Oct;
157:107879.
PMID: 31618624
Metformin, the first choice drug for type 2 diabetes treatment in all stages of therapy, and one of the most widely prescribed anti-hyperglycemic agents worldwide, represents a rare example of...
9.
Salvatore T, Nevola R, Pafundi P, Monaco L, Ricozzi C, Imbriani S, et al.
Nutrients
. 2019 Aug;
11(8).
PMID: 31412576
This review aimed to describe the potential mechanisms by which incretin hormones could mediate the relationship between glycemic index and cardiometabolic diseases. A body of evidence from many studies suggests...